Proteins
Recombinant Human Oncostatin M
- Cat.OSM01-13
- SpeciesHuman
- SourceHEK 293 cells
rhOSM purity (SDS-PAGE, left) and Stat3-Luc reporter activation in U87 glioblastoma cells (right), benchmarked against Oncostatin M from two other vendors. From the product datasheet; lot-specific values are provided on the COA.
Product details
HEK 293-expressed mature human Oncostatin M (rhOSM) at >99% purity, characterized with an ED50 of 2.5–3 ng/mL in a Stat3 activation assay.
| Catalog Number: | OSM01‐13 |
|---|---|
| Species: | Human |
| Source: | HEK 293 cells |
| Amino acids: | 26–221 |
| Protein ID: | P13725 (ONCM_HUMAN) |
| Predicted molecular weight: | 22.151 kDa |
| SDS-PAGE molecular weight: | 22 kDa (reducing conditions) |
| Purity: | >99% by SDS-PAGE (SimplyBlue SafeStain) |
| Functional activity: | ED50 2.5–3 ng/mL — Stat3 activation assay in the U87 glioblastoma cell line |
| Endotoxin: | <1 EU/µg (LAL method) |
| Formulation: | Dried from a 0.2 µm filtered solution of 20 mM Tris-HCl, 150 mM NaCl, pH 8.0 |
| Production: | Serum-free / animal-free media |
| Reconstitution: | Spin before opening; reconstitute in sterile water at ~0.1 mg/mL. Do not vortex. |
| Storage & stability: | 12 months at −20 to −80 °C (dried); after reconstitution, 6 months at −20 to −70 °C or 1 month at 2–8 °C. |
| Intended use: | For research use only. Not for use in diagnostic or therapeutic procedures. |
Functional activity
Activity-verified with an ED50 of 2.5–3 ng/mL in a Stat3 activation assay using the U87 glioblastoma cell line, measured as a full dose-response series.
Scientific background
Oncostatin M is an IL-6-family cytokine that signals through gp130 and activates the JAK/STAT pathway, including Stat3. It is studied in inflammation, tissue remodeling, hematopoiesis and cancer biology. Publications using this product are listed on the publications & resources page.
Published studies that used this product
All publications- Toll-Like receptor 3-mediated interferon-β production is suppressed by oncostatin m and a broader epithelial-mesenchymal transition programBreast Cancer Research (2024)
- Oncostatin-M and OSM-Receptor Feed-Forward Activation of MAPK Induces Separable Stem-like and Mesenchymal ProgramsMolecular Cancer Research (2023)
- Aberrant Induction of a Mesenchymal/Stem Cell Program Engages Senescence in Normal Mammary Epithelial CellsMolecular Cancer Research (2021)
- The opposing effects of interferon-beta and oncostatin-M as regulators of cancer stem cell plasticity in triple-negative breast cancerBreast Cancer Research (2019)
- Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signalingOncogene (2017)
- Potent EMT and CSC Phenotypes Are Induced By Oncostatin-M in Pancreatic CancerMolecular Cancer Research (2017)
- STAT3-mediated SMAD3 activation underlies Oncostatin M-induced SenescenceCell Cycle (2017)
More proteins
See all